Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma
Journal of Palliative Medicine · 2024
DOI: 10.1089/jpm.2023.0530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Palliative Medicine, 2024. Verfasst von Sophia Shimer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Prior studies reveal a lack of illness understanding and prognostic awareness among patients with hematological malignancies. We evaluated prognostic awareness and illness understanding among patients with acute leukemia and multiple myeloma (MM) and measured patient-hematologist discordance.
Methods
We prospectively enrolled patients with acute leukemia and MM at Mount Sinai Hospital or Yale New Haven Hospital between August 2015 and February 2020. Patients were administered a survey assessing prognostic awareness, goals of care (GOC), and quality of life. Hematologists completed a similar survey for each patient. We assessed discordance across the cohort of patients and hematologists using the likelihood-ratio chi-square test and within patient-hematologist pairs using the kappa (κ) statistic.
Results
We enrolled 185 patients (137 with leukemia and 48 with MM) and 29 hematologists. Among patients, 137 (74%) self-identified as White, 27 (15%) as Black, and 21 (11%) as Hispanic. Across the entire cohort, patients were significantly more optimistic about treatment goals compared with hematologists (p = 0.027). Within patient-hematologist pairs, hematologists were significantly more optimistic than patients with respect to line of treatment (κ = 0.03). For both leukemia and MM cohorts, patients were significantly more likely to respond "don't know" or deferring to a faith-based response with 88 (64%) and 34 (71%), respectively, compared with only 28 (20%) and 11 (23%) of hematologists, respectively.
Conclusions
We observed significant discordance regarding prognosis and GOC among patients with hematological malignancies and their hematologists. These data support future interventions to improve prognostic understanding among this patient population to facilitate informed treatment choices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale School of Medicine, New Haven, Connecticut, USA.
- Beth Israel Deaconess Medical Center, New Haven, Connecticut, USA.
- Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA.
- Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Alaska Oncology and Hematology, Anchorage, Alaska, USA.
- Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Cardinale B Smith
Zitieren
APA
Shimer, S., Allen, O. S., Yang, C., Canavan, M., Westvold, S., Kim, N., Morillo, J., Parker, T., Wallace, N., Smith, C. B., & Adelson, K. B. (2024). Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2023.0530
Vancouver
Shimer S, Allen OS, Yang C, Canavan M, Westvold S, Kim N, et al. Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma. Journal of Palliative Medicine. 2024. doi:10.1089/jpm.2023.0530
BibTeX
@article{Shimer2024,
author = {Shimer, Sophia and Allen, Olivia S and Yang, Chen and Canavan, Maureen and Westvold, Sarah and Kim, Nina and Morillo, Jose and Parker, Terri and Wallace, Natalie and Smith, Cardinale B and Adelson, Kerin B},
title = {Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma},
journal = {Journal of Palliative Medicine},
year = {2024},
doi = {10.1089/jpm.2023.0530}
}
EUVIMED